- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05083234
Maintaining Skin Integrity in Neonates With Sunflower Seed Oil and Liquid Vaseline (Neonates)
Maintaining Skin Integrity in Neonates With Sunflower Seed Oil and Liquid Vaseline: A Prospective Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Because the barrier function of the skin of the newborn is still immature, disruption of skin integrity is a commonly observed problem. The purpose of the study was to test the applicability and effectiveness of sunflower seed oil (SSO) and Liquid Vaseline (LV) in maintaining skin integrity in term and preterm neonates in the Neonatal Intensive Care Unit (NICU). The sample size of the study has been determined by the power analysis (G*Power 3.1.9.2), The sample size was found to be a total of 66 neonates including minimum of 22 neonates for each group. It was estimated that case losses may occur and therefore, it was decided to conduct the study with a total of 90 neonates including 30 neonates in three groups. Assignment of neonates to research groups was done according to the order of hospitalization in the NICU. The first hospitalized neonates SSO, the second hospitalized LV, and the third hospitalized were included in the control group. The groups were repeated until they were complete. Weighing the neonate, taking vital signs, evaluating the skin condition, wiping the whole body, and stabilizing the general condition of the neonate before moisturizing the skin were taken into account. Neonates Information Form(NIF) and Neonatal Skin Condition Score (NSCS) were used for data collection. Parents of neonates were informed about the study. First day of hospitalization; Demographic data and medical history of the neonate in the study or control group were obtained from the patient file records. The neonate was weighed, vital signs were taken, and the data were recorded in the NIF.
The body of all neonates in the research or control group was wiped on the 1st day of hospitalization. In the following days, it was repeated 2 times a week (Monday and Friday) in the same way.The skin condition of the neonate in the research or control group was evaluated with the NSCS scale. The first skin evaluation was performed on the 1st day of hospitalization (1st NSCS). Skin condition was re-evaluated at 48 hour intervals in the following days. Skin condition of the neonate in the control or research group was evaluated a total of 9 times with 48-hour intervals. After the initial skin condition assessment, the neonate's skin is moistened with SSO or LV, depending on the group. It was rehydrated once a day (24 hours apart) in the following days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Küçükçekmece
-
Istanbul, Küçükçekmece, Turkey, 11349921
- Kanuni Sultan Süleyman Research and Training Hospital NICU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents giving verbal and written consent,
- Hospitalized in the NICU within the first 24 hours after birth,
- With a birth weight of more than 1500 g,
- No life-threatening health problems and skin diseases.
Exclusion Criteria:
- Gestational age less than 32 weeks,
- Parents who do not give verbal and written permission,
- Hospitalized in the NICU after the first 24 hours after birth,
- With a birth weight of less than 1500 g,
- Having life-threatening health problems and skin diseases.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sunflower Seed Oil Group (SSO)
The skin of newborns in the sunflower seed oil group was moisturized with SSO
|
Vital signs of newborns in the sunflower seed oil group were measured.
The skin of newborns in the sunflower seed oil group was wiped without rubbing.
The skin of newborns in the sunflower seed oil group was evaluated with the NSCS scale.
|
|
Experimental: Liquid Vaseline Group (LV)
The skin of newborns in the liquid vaseline group was moisturized with LV.
|
Vital signs of newborns in the liquid vaseline group were measured.
The skin of newborns in the liquid vaseline group was wiped without rubbing.
The skin of newborns in the liquid vaseline group was evaluated with the NSCS scale.
|
|
Experimental: Control Group
The skin of newborns in the control group was not moisturized.
|
Vital signs of newborns in the control group were measured.
The skin of newborns in the control group was wiped without rubbing.
The skin of newborns in the control group was evaluated with the NSCS scale.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin condition score of newborns
Time Frame: Change from skin condition score of newborns at 16 days
|
The NSCS was developed for clinical nurses to use to evaluate infant skin condition.
The scale evaluates skin dryness, erythema, and eruption.
The best and worst possible scores are 3 and 9, respectively.
The scale does not have a cutoff value.
High scores indicate poor skin condition, and low scores indicate normal skin condition
|
Change from skin condition score of newborns at 16 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Behice Ekici, PhD, Maltepe University School of Nursing
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-10-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nursing Caries
-
Kastamonu UniversityRecruiting
-
Bilecik Seyh Edebali UniversitesiThe Scientific and Technological Research Council of TurkeyRecruitingNursing CariesTurkey
-
University of BeykentCompleted
-
Inonu UniversityCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingNursing Caries | Nurse's Role | Nursing StudentsTurkey
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingNursing Caries | Stoma Colostomy | Nursing Student
-
Hitit UniversityCompletedNursing CariesTurkey
-
Ankara UniversityCompletedNursing CariesTurkey
-
T.C. ORDU ÜNİVERSİTESİCompleted
Clinical Trials on Moisturizing with SSO
-
University of British ColumbiaL'OrealNot yet recruiting
-
Solventum US LLC3MCompleted
-
USMARI Research & Innovation CentreRecruiting
-
Bircan Kahraman BerberogluAydin Adnan Menderes UniversityCompleted
-
Institute of Dermatology, ThailandRecruitingEfficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis (Pilot RCT)Seborrheic Dermatitis on the FaceThailand
-
Societa Italiana di Dermatologia Medica, Chirurgica...Recruiting
-
Petra LarmoTekes - The Finnish Funding Agency for Technology and Innovation; Turun Silmäexpertit... and other collaboratorsCompleted
-
Galderma R&DCompletedSkin IrritationUnited States
-
Nova Scotia Health AuthorityDalhousie UniversityUnknownXerostomia | Hyposalivation
-
NovoBliss Research Pvt LtdBlossom Microbiotics LLCNot yet recruiting